ストックスクリーナーアプリを入手
0.3499
0.71%
-0.000100
アフターアワーズ：
.35
0.000100
+0.03%
前日終値:
$0.35
開ける：
$0.35
24時間の取引高:
132.14K
Relative Volume:
1.55
時価総額：
$5.53M
収益：
-
当期純損益:
$-19.09M
株価収益率:
-0.1699
EPS:
-2.06
ネットキャッシュフロー:
$-16.92M
1週間 パフォーマンス:
-4.53%
1か月 パフォーマンス:
-24.78%
6か月 パフォーマンス:
-66.26%
1年 パフォーマンス:
-72.42%
1日の値動き範囲:
$0.321
$0.3599
1週間の範囲:
$0.3154
$0.435
52週間の値動き範囲:
$0.3154
$1.74
Organovo Holdings Inc Stock (ONVO) Company Profile
名前
Organovo Holdings Inc
セクター
電話
858-224-1000
住所
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
ONVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| ONVO | 0.3499 | 5.53M | 0 | -19.09M | -16.92M | -2.06 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-12-13 | 開始されました | H.C. Wainwright | Buy |
| 2017-11-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | 開始されました | Raymond James | Outperform |
| 2015-08-11 | ダウングレード | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | 開始されました | Jefferies | Buy |
| 2015-06-29 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Organovo Holdings Inc (ONVO) 最新ニュース
ONVOOrganovo Holdings Inc. Latest Stock News & Market Updates - StockTitan
Organovo reports positive Phase 2 results for liver drug FXR314 By Investing.com - Investing.com South Africa
Organovo reports positive Phase 2 results for liver drug FXR314 - Investing.com India
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - The Manila Times
Organovo's FXR314 Shows Significant Liver Fat Reduction in Phase 2 MASH Trial | ONVO Stock News - StockTitan
Human Liver Models Market 2024-2031| Emerging Technologies, - openPR
Organovo stock plunges to 52-week low of $0.35 amid market challenges - Investing.com India
3D Bioprinting Market Projected to Reach $$$ Billion by 2031 with - openPR
Armistice Capital, LLC Increases Stake in Organovo Holdings Inc - GuruFocus.com
Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight - GlobeNewswire Inc.
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases - The Manila Times
Organovo's FXR314 Drug Trial Data Selected for Major Liver Conference Presentation | ONVO Stock News - StockTitan
3D Printer Market to Grow by USD 30 Billion (2024-2028), Driven by Rising Consumer Demand for Customized Products, AI-Powered Report Highlights Market TransformationTechnavio - The Malaysian Reserve
Is Health Care's Hottest Stock a Mirage? - AOL
Organovo: Fiscal Q2 Earnings Snapshot - San Antonio Express-News
Organovo stock plunges to 52-week low of $0.39 amid market challenges - Investing.com
Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World
Organovo stock plunges to 52-week low of $0.42 amid market challenges - Investing.com Canada
Organovo (NASDAQ:ONVO) Receives New Coverage from Analysts at StockNews.com - Defense World
How Quickly Can Organovo Holdings Generate Revenue? - AOL
Organovo stock hits 52-week low at $0.43 amid market challenges - Investing.com Australia
Organovo stock hits 52-week low at $0.43 amid market challenges By Investing.com - Investing.com South Africa
Organovo Holdings (FRA:4OR1) Peter Lynch Fair Value : €-19.81 (As of Oct. 09, 2024) - GuruFocus.com
3D Bioprinting Technologies Market Outlook 2024-2031: Trends - openPR
Organovo stock plunges to 52-week low of $0.5 amid market challenges - Investing.com Australia
Analyzing Organovo (NASDAQ:ONVO) & Turnstone Biologics (NASDAQ:TSBX) - Defense World
3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy - GlobeNewswire
3D Bioprinting For Regenerative Medicine Market Focusing On - openPR
3D Printing Metals Market is set for a Potential Growth Worldwide: Hoganas, Organovo, Ponoko - Talented India
Human Liver Models Market to Witness Huge Growth by 2031 - openPR
Organovo (NASDAQ:ONVO) Now Covered by Analysts at StockNews.com - Defense World
Organovo Holdings (LTS:0R02) GF Value Rank : 0 (As of Aug. 17, 2024) - GuruFocus.com
Organovo Holdings (LTS:0R02) Price-to-Operating-Cash-Flow : (As of Aug. 17, 2024) - GuruFocus.com
Organovo Holdings (LTS:0R02) Financial Strength : 3 (As of Jun. 2024) - GuruFocus.com
Organovo Holdings (STU:4OR1) Float Percentage Of Total Shar - GuruFocus.com
Organovo Holdings (STU:4OR1) EV-to-Revenue : 49.10 (As of Aug. 16, 2024) - GuruFocus.com
3D Bioprinting Market Giants Spending Is Going To Boom | Envisiontec, Organovo Holdings, Cellink Global - Newstrail
Organovo grants stock options to executive chairman - Investing.com India
Organovo Holdings Grants Stock Options to Executive Chairman - TipRanks
Organovo Holdings, Inc. Forecasted to Post Q2 2025 Earnings of ($0.26) Per Share (NASDAQ:ONVO) - Defense World
3D Printing Metals Market Is Booming Worldwide | Hoganas, Organovo, Ponoko - openPR
Organovo stock hits 52-week low at $0.51 amid market challenges - Investing.com
Understand the 3D Bioprinting Market’s Future CAGR of 12.95%: Key Drivers, Innovations, and Insights to 203... - WhaTech
3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio - The Malaysian Reserve
Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World
Organovo Holdings hits 52-week low, trading at 0.55 USD - Investing.com
Organovo Holdings hits 52-week low, trading at 0.55 USD By Investing.com - Investing.com Nigeria
3D Bioprinting Market Trends and Regional Analysis | Organovo Holdings Inc. (U.S.), Cellink AB (Sweden), Stratasys Ltd. (U.S.) – Economica - Economica
3D Printing Medical Devices Market Is Booming Worldwide | Fluicell, Organovo, Renishaw - openPR
Organovo Holdings Inc (ONVO) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.56%
大文字化:
|
ボリューム (24 時間):